GO
Loading...

Enter multiple symbols separated by commas

Celgene Corp

More

  • *Jobless claims lowest since 2000. April 30- U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed. The Nasdaq biotech index dropped 3.1 percent on Thursday, led by a 4.5 percent fall in Celgene, which reported lower-than-expected quarterly revenue.

  • NEW YORK, April 30- Stock markets worldwide posted a second straight session of losses on Thursday after more weak earnings reports, with all three major U.S. indexes plunging more than 1 percent. Celgene led a fall in U.S. biotech stocks, while shares of Harman International Industries fell 7 percent after the maker of audio systems cut its 2015 profit forecast.

  • April 30- U.S. stocks sold off on Thursday, led by a drop in the Nasdaq, as Apple shares declined and results in tech and biotech names disappointed. The Nasdaq biotech index dropped 3.1 percent, led by a 4.5 percent fall in Celgene, which reported lower-than-expected quarterly revenue. Apple was down 2.7 percent at $125.15 and was the biggest drag on the Dow, S&P 500...

  • And that kind of colored the statement more hawkish for the Fed, "said Bucky Hellwig, senior vice president at BB&T Wealth Management in Birmingham, Alabama. The Nasdaq biotech index dropped 3.2 percent, led by a 3.9 percent fall in Celgene, which reported lower-than-expected quarterly revenue. The company limited the availability of the Apple Watch after a key...

  • *Apple and Celgene weigh on Nasdaq, S&P 500. April 30- Wall Street was lower in midday trading on Thursday as Apple weighed on major indexes and investors digested a mixed batch of economic data. Apple fell as much as 2.5 percent to $125.45 and was the biggest drag on the Dow, S&P 500 and the Nasdaq.

  • NEW YORK, April 30- Stock markets worldwide stumbled for a second straight day on Thursday after more weak earnings reports, while the dollar trimmed losses after hitting fresh nine-week lows. Weak quarterly earnings from Celgene led a fell in U.S. biotech shares, while shares of Harman International Industries fell over 7 percent after the maker of audio...

  • Poor earnings send stocks lower; utilities, tech slump Thursday, 30 Apr 2015 | 12:03 PM ET

    NEW YORK— Stocks are heading lower in midday trading, led by declines in utilities and technology companies. Harman International, which makes audio systems for cars, Varian Medical Systems and Celgene all dropped in midday trading Thursday after their revenue fell short of analysts' estimates. The Dow Jones industrial average lost 78 points, or 0.4 percent, to...

  • US STOCKS-Wall St opens lower as Apple, Celgene weigh Thursday, 30 Apr 2015 | 10:39 AM ET

    *Apple and Celgene weigh on Nasdaq, S&P 500. April 30- Wall Street opened lower on Thursday as Apple weighed on the major indexes and Celgene led a fall in biotech stocks, more than offsetting encouraging economic data. The company limited availability of the Apple Watch after a key component supplied by a Chinese company was found to be defective, according to the...

  • Poor batch of earnings send stocks lower in early trade Thursday, 30 Apr 2015 | 9:40 AM ET

    NEW YORK— A weak batch of earnings reports is sending the stock market slightly lower in early trading. Harman International, which makes audio systems for cars, Varian Medical Systems and Celgene all dropped in early trading Thursday after their revenue fell short of analysts' estimates. The Dow Jones industrial average lost 13 points, or 0.1 percent, to at...

  • April 30- U.S. biotechnology company Celgene Corp posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast. Celgene in late January had forecast 2015 adjusted profit of $4.60- $4.75 per share, on net product sales of $9.0- $9.5 billion, including a near...

  • Celgene tops 1Q profit forecasts Thursday, 30 Apr 2015 | 7:51 AM ET

    SUMMIT, N.J. _ Celgene Corp. on Thursday reported first-quarter profit of $718.9 million. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.06 per share. Celgene shares have increased 1 percent since the beginning of the year, while the Standard& Poor's 500 index has climbed slightly more than 2 percent.

  • April 30- Celgene Corp's quarterly profit more than doubled, driven by higher demand in the United States for its flagship multiple myeloma drug, Revlimid. The company's net profit rose to $718.9 million, or 86 cents per share, in the first quarter ended March 31, from $279.7 million, or 33 cents per share on a stock split-adjusted basis, a year earlier.

  • Final Glance: Biotechnology companies Wednesday, 29 Apr 2015 | 6:14 PM ET

    Amgen Inc. fell $1.51 or. 9 percent, to $160.98. Biogen Idec rose $9.10 or 2.4 percent, to $383.78. Celgene Corp. fell$. 32 or. 3 percent, to $113.20.

  • Midday Glance: Biotechnology companies Wednesday, 29 Apr 2015 | 2:53 PM ET

    Amgen Inc. fell $1.39 or. 9 percent, to $161.10. Biogen Idec rose $8.25 or 2.2 percent, to $382.93. Celgene Corp. fell$. 69 or. 6 percent, to $112.83.

  • Early Glance: Biotechnology companies Wednesday, 29 Apr 2015 | 10:45 AM ET

    Amgen Inc. rose$. 60 or. 4 percent, to $163.09. Biogen Idec rose $9.40 or 2.5 percent, to $384.08. Celgene Corp. rose$. 30 or. 3 percent, to $113.82.

  • Final Glance: Biotechnology companies Tuesday, 28 Apr 2015 | 6:04 PM ET

    Amgen Inc. rose$. 11 or. 1 percent, to $162.49. Biogen Idec fell $14.59 or 3.7 percent, to $374.68. Celgene Corp. fell $1.20 or 1.0 percent, to $113.52.

  • Midday Glance: Biotechnology companies Tuesday, 28 Apr 2015 | 1:50 PM ET

    Amgen Inc. rose $2.04 or 1.3 percent, to $164.42. Biogen Idec fell $8.05 or 2.1 percent, to $381.22. Celgene Corp. fell$. 81 or. 7 percent, to $113.91.

  • Early Glance: Biotechnology companies Tuesday, 28 Apr 2015 | 10:39 AM ET

    Amgen Inc. fell$. 23 or. 1 percent, to $162.15. Biogen Idec fell $8.74 or 2.2 percent, to $380.53. Celgene Corp. fell $1.03 or. 9 percent, to $113.69.

  • Final Glance: Biotechnology companies Monday, 27 Apr 2015 | 6:06 PM ET

    Amgen Inc. fell $5.53 or 3.3 percent, to $162.38. Biogen Idec fell $12.44 or 3.1 percent, to $389.27. Celgene Corp. fell $4.00 or 3.4 percent, to $114.72.

  • Midday Glance: Biotechnology companies Monday, 27 Apr 2015 | 1:50 PM ET

    Amgen Inc. fell $5.07 or 3.0 percent, to $162.84. Biogen Idec fell $11.37 or 2.8 percent, to $390.34. Celgene Corp. fell $3.51 or 3.0 percent, to $115.20.